Clinical practice guideline based on the evidence for the management of sedoanalgesia in the critically ill adult patient;Guía de práctica clínica basada en la evidencia para el manejo de la sedo-analgesia en el paciente adulto críticamente enfermo

Medicina Intensiva

Volumn 31, Issue 8, 2007, Pages 428-471

  Celis Rodriguez E ^a   Besso, J ^a   Birchenall, C ^a   De La Cal, M A ^a   Carrillo, R ^a   Castorena, G ^a   Ceraso, D ^a   Duenas C ^a   Gil, F ^a   Jimenez E ^a   Meza, J C ^a   Munoz M ^a   Pacheco, C ^a   Palizas F ^a   Pinilla, D ^a   Raffan F ^a   Raimondi, N ^a   Rubiano, S ^a   Suarez M ^a   Ugarte, S ^a  

^a Torre 5 ^*

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; BUPIVACAINE; BUPRENORPHINE; CHLORIDE; CHLORPROMAZINE; CLONIDINE; DEXMEDETOMIDINE; DIHYDROMORPHINE; DROPERIDOL; ETOMIDATE; FENTANYL; HALOPERIDOL; LORAZEPAM; METHADONE; MIDAZOLAM; MORPHINE; NALBUPHINE; OLANZAPINE; PENTOBARBITAL; PETHIDINE; PROPOFOL; REMIFENTANIL; RISPERIDONE; SUFENTANIL;

AGITATION; ARTIFICIAL VENTILATION; CLINICAL PRACTICE; CONFERENCE PAPER; CONTINUOUS INFUSION; DELIRIUM; DYSTONIA; ENDOTRACHEAL INTUBATION; EXTRAPYRAMIDAL SYNDROME; FOOD AND DRUG ADMINISTRATION; HUMAN; HYPOTENSION; INTENSIVE CARE; KIDNEY FAILURE; LIVER FAILURE; MEDICAL LITERATURE; MUSCLE SPASM; NEUROSURGERY; PATIENT CARE; POSTOPERATIVE CARE; RATING SCALE; SEDATION; TREATMENT CONTRAINDICATION; WITHDRAWAL SYNDROME;

EID: 36248994582     PISSN: 02105691     EISSN: 15786749     Source Type: Journal    
DOI: 10.1016/S0210-5691(07)74853-2     Document Type: Conference Paper

References (284)

1. Tung A, Rosenthal M. Patients requiring sedation. Crit Care Clin. 1995;11:791-802.
2. Cohen IL, Gallagher TJ, Pohlman AS, Dasta JF, Abraham E, Papadokos PJ. Management of the agitated intensive care unit patient. Crit Care Med. 2002;30:S97-S123.
3. Jacobi J, Fraser GL, Coursin DB, Riker RR, Fontaine D, Wittbrodt ET, et al. Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult. Crit Care Med. 2002;30:119-41.
4. Guyatt G, Gutterman D, Baumann MH, Addrizzo-Harris D, Hylek EM, Phillips B, et al. Grading strength of recommendations and quality of evidence in clinical guidelines. Report from an American College of Chest Physicians Task Force. Chest 2006;129:174-81.
5. Fraser GL, Prato BS, Riker RR, Berthiaume D, Wilkins ML. Frequency, severity, and treatment of agitation in young versus elderly patients in the ICU. Pharmacotherapy. 2000;20:75-82.
6. Woods JC, Mion LC, Connor JT, Viray F, Jahan L, Huber C, et al. Severe agitation among ventilated medical intensive care unit patients. frequency, characteristics and outcomes. Intensive Care Med. 2004;30:1066-72.
7. Kress JP, Pohlman AS, Hall JB. Sedation and analgesia in the intensive care unit. Am J Respir Crit Care Med. 2002;166: 1024-8.
8. Sessler CN. Comfort and distress in the ICU scope of the problem. Semin Respir Crit Care Med. 2001;22:111-4.
9. Carrion MI, Ayuso D, Marcos M, Paz RM, de la Cal MA, Alia I, et al. Accidental removal of endotracheal and nasogastric tubes and intravascular catheters. Crit Care Med. 2000;28:63-6.
10. Fraser GL, Riker RR, Prato BS, Wilkins ML. The frequency and cost of patient-initiated device removal in the ICU. Pharmacotherapy. 2001;21:1-6.
11. Weissman C, Kemper M. The oxygen uptake-oxygen delivery relationship during ICU interventions. Chest 1991;99:430-5.
12. Frazier SK, Moser DK, O'Brien JL, Garvin BJ, An K, Macko M. Management of anxiety after acute myocardial infarction. Heart Lung. 2002;31:411-20.
13. Ramsay MA, Savege TM, Simpson BR, Goodwin R. Controlled sedation with alphaxalone-alphadolone. Br Med J. 1974;2:656-9.
14. Devlin JW, Boleski G, Mlynarek M, Nerenz DR, Peterson E, Jankowski M, Horst HM, Zarowitz BJ. Motor Activity Assessment Scale. a valid and reliable sedation scale for use with mechanically ventilated patients in an adult surgical intensive care unit. Crit Care Med. 1999;27:1271-5.
15. Riker RR, Picard JT, Fraser GL. Prospective evaluation of the Sedation-Agitation Scale for adult critically ill patients. Crit Care Med. 1999;27:1325-9.
16. Riker RR, Fraser GL, Simmons LE, Wilkins ML. Validating the Sedation-Agitation Scale with the Bispectral Index and Visual Analog Scale in adult ICU patients after cardiac surgery. Intensive Care Med. 2001;27:853-8.
17. Ely EW, Truman B, Shintani A, Thomason JW, Wheeler AP, Gordon S, et al. Monitoring sedation status over time in ICU patients: reliability and validity of the Richmond Agitation-Sedation Scale (RASS). JAMA. 2003;89:2983-91.
18. Brandl KM, Langley KA, Riker RR, Dork LA, Quails CR, Levy H. Confirming the reliability of the sedation-agitation scale administered by ICU nurses without experience in its use. Pharmacotherapy. 2001;21:431-6.
19. Sessler CN, Gosnell MS, Grap MJ, Brophy GM, O'Neal PV, et al. The Richmond Agitation-Sedation Scale: validity and reliability in adult intensive care unit patients. Am J Respir Crit Care Med. 2002;166:1338-44.
20. Chinchilla A, Quintero A, Correas J, Vega M. Manual de urgencies psiquiátricas, parte I. Conceptos básicos. Barcelona: Masson, 2004.
21. Manninen PH, Chan AS, Papworth D. Conscious sedation for interventional neuroradiology: a comparison of midazolam and propofol infusion. Can J Anaesth. 1997;44:26-30.
22. Waring JP, Baron TH, Hirota WK, Goldstein JL, Jacobson BC, Leighton JA, et al. Guidelines for conscious sedation and monitoring during gastrointestinal endoscopy. Gastrointest Endosc. 2003;58:317-22.
23. Chávez OM, Mendoza M, Guedez R, Zavala M., Lazorza C. Sedación de Pacientes en Ventilación Mecánica. Parte I. MEDICRIT. 2005;2:49-54.
24. Duke P, Maze M, Morrison L. Dexmedetomidine:a general overview. In: Maze M, Morrison P, eds. Refefining sedation: International Congress and Symposium Series 221. London: The Royal Society of Medicine Press Ltd, 1998. p. 11-22.
25. Venn RM, Bradshaw CJ, Spencer R, Brealey D, Caudwell E, Naughton C, et al. Preliminary UK experience of dexmedetomidine, a novel agent for postoperative sedation in the intensive care unit. Anaesthesia. 1999;54:1136-42.
26. Bhana N, Goa KL, McClellan KJ. Dexmedetomidine. Drugs. 2000;59:263-8.
27. Venn RM, Hell J, Grounds RM. Respiratory effects of dexmedetomidine in the surgical patient requiring intensive care. Crit Care. 2000;4:302-8.
28. Venn RM, Grounds RM. Comparison between dexmedetomidine and propofol for sedation in the intensive care unit: patient and clinician perceptions. Br J Anaesth. 2001;87:684-90.
29. Shehabi Y, Ruettimann U, Adamson H, Innes R, Ickeringill M. Dexmedetomidine infusion for more than 24 hours in critically ill patients: sedative and cardiovascular effects. Intensive Care Med. 2004;30:2188-96.
30. Gerlach AT, Dasta JF. Dexmedetomidine: an updated review. Ann Pharmacother. 2007;41:245-52.
31. Wagner BK, O'Hara DA. Pharmacokinetics and pharmacodynamics of sedatives and analgesics in the treatment of agitated critically ill patients. Clin Pharmacokinet. 1997;33:426-53.
32. Reves JG, Fragen RJ, Vinik HR, Greenblatt DJ. Midazolam: pharmacology and uses. Anesthesiology. 1985;62: 310-24.
33. Albanese J, Martin C, Lacarelle B, Saux P, Durand A, Gouin F. Pharmacokinetics of long-term propofol infusion used for sedation in ICU patients. Anesthesiology. 1990;73:214-7.
34. Shafer A, Doze VA, White PF. Pharmacokinetic variability of midazolam infusions in critically ill patients. Crit Care Med. 1990;18:1039-41.
35. Bailie GR, Cockshott ID, Douglas EJ, Bowles BJ. Pharmacokinetics of propofol during and after long-term continuous infusion for maintenance of sedation in ICU patients. Br J Anaesth. 1992;68:486-91.
36. Malacrida R, Fritz ME, Suter PM, Crevoisier C. Pharmacokinetics of midazolam administered by continuous intravenous infusion to intensive care patients. Crit Care Med. 1992;20:1123-6.
37. Taylor E, Ghouri AF, White PF. Midazolam in combination with propofol for sedation during local anesthesia. J Clin Anesth. 1992;4:213-6.
38. Fulton B, Sorkin EM. Propofol. An overview of its pharmacology and a review of its clinical efficacy in intensive care sedation. Drugs. 1995;50:636-57.
39. Miller DR, Blew PG, Martineau RJ, Hull KA. Midazolam and awareness with recall during total intravenous anaesthesia. Can J Anaesth. 1996;43. 946-53.
40. Pachulski RT, Adkins DC, Mirza H. Conscious sedation with intermittent midazolam and fentanyl in electrophysiology procedures. J Interv Cardiol. 2001;14:143-6.
41. Anderson KJ, Leitch JA, Green JS, Kenny GN. Effect-site controlled patient maintained propofol sedation: a volunteer safety study. Anaesthesia. 2005;60 :235-8.
42. Servin F. Pharmacologie du droperidol. Encycl Med Chir. Paris, Editions Techniques, 1994, p 368.
43. Kao LW, Kirk MA, Evers SJ, Rosenfeld SH. Droperidol, QT prolongation, and sudden death. what is the evidence? Ann Emerg Med. 2003;41:546-58.
44. White PF, Song D, Abrao J, Klein KW, Navarette B. Effect of low-dose droperidol on the QT interval during and after general anesthesia. A placebo-controlled study. Anesthesiology. 2005;102:1101-5.
45. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th Edition. Washington, DC: American Psychiatric Pub, Inc. 2000; pp. 135-7.
46. Inouye SK. The dilemma of delirium. clinical and research controversies regarding diagnosis and evaluation of delirium in hospitalized elderly medical patients. Am J Med. 1994;97:278-88.
47. Sanders AB. Missed delirium in older emergency department patients: a quality-of-care problem. Ann Emerg Med. 2002;39:338-41.
48. Trzepacz PT, Mulsant BH, Dew MA, Pasternak R, Sweet RA, Zubenko GS. Is delirium different when it occurs in dementia? A study using the delirium rating scale. J Neuropsychiatry Clin Neurosci. 1998;10:199-204.
49. O'Keeffe ST, Lavan JN. Clinical significance of delirium subtypes in older people. Age Ageing. 1999;28:115-9.
50. Justic M. Does "ICU psychosis" really exist? Crit Care Nurse. 2000;20:28-37.
51. Meagher DJ, O'Hanlon D, O'Mahony E, Casey PR, Trzepacz PT. Relationship between symptoms and motoric subtype of delirium. J Neuropsychiatry Clin Neurosci. 2000;12:51-6.
52. Meagher DJ, Trzepacz PT. Motoric subtypes of delirium. Semin Clin Neuropsychiatry. 2000;5:75-85.
53. Inouye SK, Viscoli CM, Horwitz RI, Hurst LD, Tinetti ME. A predictive model for delirium in hospitalized elderly medical patients based on admission characteristics. Ann Intern Med. 1993;119:474-81.
54. Inouye SK, Charpentier PA. Precipitating factors for delirium in hospitalized elderly persons. Predictive model and interrelationship with baseline vulnerability. JAMA. 1996;275:852-7.
55. Williams-Russo P, Urquhart BL, Sharrock NE, Charlson ME. Post-operative delirium. predictors and prognosis in elderly orthopedic patients. J Am Geriatr Soc. 1992;40:759-67.
56. Marcantonio ER, Juarez G, Goldman L, Mangione CM, Ludwig LE, Lind L, et al. The relationship of postoperative delirium with psychoactive medications. JAMA. 1994;272:1518-22.
57. Lynch EP, Lazor MA, Gellis JE, Orav J, Goldman L, Marcantonio ER. The impact of postoperative pain on the development of postoperative delirium. Anesth Analg. 1998;86:781-5.
58. Inouye SK, Bogardus ST, Jr., Charpentier PA, Leo-Summers L, Acampora D, Holford TR, et al. A multicomponent intervention to prevent delirium in hospitalized older patients. N Engl J Med. 1999;340:669-76.
59. Hart RP, Levenson JL, Sessler CN, Best AM, Schwartz SM, Rutherford LE. Validation of a cognitive test for delirium in medical ICU patients. Psychosomatics. 1996;37:533-46.
60. Ely EW, Margolin R, Francis J, May L, Truman B, Dittus RS, et al. Evaluation of delirium in critically ill patients: validation of the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU). Crit Care Med. 2001;29:1370-9.
61. Ely EW, Inouye SK, Bernard GR, Gordon S, Francis J, May L, et al. Delirium in mechanically ventilated patients:validity and reliability of the confusion assessment method for the intensive care unit (CAM-ICU). JAMA. 2001;286:2703-10.
62. Bergeron N, Skrobik Y, Dubois MJ. Delirium in critically ill patients. Crit Care. 2002;6:181-2.
63. www.icudelirium.org/delirium/CAM-ICUTraining.html. [Acceso 15-7-2007].
64. Milisen K, Foreman MD, Abraham IL, De GS, Godderis J, Vandermeulen E, et al. A nurse-led interdisciplinary intervention program for delirium in elderly hip-fracture patients. J Am Geriatr Soc. 2001;49:523-32.
65. Bogardus ST, Jr., Desai MM, Williams CS, Leo-Summers L, Acampora D, Inouye SK. The effects of a targeted multicomponent delirium intervention on postdischarge outcomes for hospitalized older adults. Am J Med. 2003;114:383-90.
66. Tesar GE, Murray GB, Cassem NH. Use of high-dose intravenous haloperidol in the treatment of agitated cardiac patients. J Clin Psychopharmacol. 1985;5:344-7.
67. Riker RR, Fraser GL, Cox PM. Continuous infusion of haloperidol controls agitation in critically ill patients. Crit Care Med. 1994;22:433-40.
68. Levenson JL. High-dose intravenous haloperidol for agitated delirium following lung transplantation. Psychosomatics. 1995;36:66-8.
69. Seneff MG, Mathews RA. Use of haloperidol infusions to control delirium in critically ill adults. Ann Pharmacother. 1995;29:690-3.
70. Brown RL, Henke A, Greenhalgh DG, Warden GD. The use of haloperidol in the agitated, critically ill pediatric patient with burns. J Burn Care Rehabil. 1996;17:34-8.
71. Hassan E, Fontaine DK, Nearman HS. Therapeutic considerations in the management of agitated or delirious critically ill patients. Pharmacotherapy. 1998;18:113-29.
72. Ely EW, Stephens RK, Jackson JC, Thomason JW, Truman B, Gordon S, et al. Current opinions regarding the importance, diagnosis, and management of delirium in the intensive care unit. a survey of 912 healthcare professionals. Crit Care Med. 2004;32:106-12.
73. Skrobik YK, Bergeron N, Dumont M, Gottfried SB. Olanzapine vs haloperidol: treating delirium in a critical care setting. Intensive Care Med. 2004;30:444-9.
74. Marx CM, Rosenberg DI, Ambuel B, Hamlett KW, Blumer JL. Pediatric intensive care sedation: survey of fellowship training programs. Pediatrics. 1993;91:369-78.
75. Fonsmark L, Rasmussen YH, Carl P. Occurrence of withdrawal in critically ill sedated children. Crit Care Med. 1999;27:196-9.
76. Tobias JD. Subcutaneous administration of fentanyl and midazolam to prevent withdrawal after prolonged sedation in children. Crit Care Med. 1999;27:2262-5.
77. Hantson P, Clemessy JL, Baud FJ. Withdrawal syndrome following midazolam infusion. Intensive Care Med. 1995;21:190-1.
78. Katz R, Kelly HW, Hsi A. Prospective study on the occurrence of withdrawal in critically ill children who receive fentanyl by continuous infusion. Crit Care Med. 1994;22:763-7.
79. Puntillo K, Casella V, Reid M. Opioid and benzodiazepine tolerance and dependence: application of theory to critical care practice. Heart Lung. 1997;26:317-24.
80. Taylor D. Iatrogenic drug dependence - a problem in intensive care? Case study and literature review. Intensive Crit Care Nurs. 1999;15:95-100.
81. Mellman TA, Uhde TW. Withdrawal syndrome with gradual tapering of alprazolam. Am J Psychiatry. 1986;143:1464-6.
82. Finley PR, Nolan PE, Jr. Precipitation of benzodiazepine withdrawal following sudden discontinuation of midazolam. DICP. 1989;23:151-2.
83. Bergman I, Steeves M, Burckart G, Thompson A. Reversible neurologic abnormalities associated with prolonged intravenous midazolam and fentanyl administration. J Pediatr. 1991;119:644-9.
84. Rosen DA, Rosen KR. Midazolam for sedation in the paediatric intensive care unit. Intensive Care Med. 1991;17 Suppl 1:S15-S19.
85. Freda JJ, Bush HL, Jr., Barie PS. Alprazolam withdrawal in a critically ill patient. Crit Care Med. 1992;20:545-6.
86. Sury MR, Billingham I, Russell GN, Hopkins CS, Thornington R, Vivori E. Acute benzodiazepine withdrawal syndrome after midazolam infusions in children. Crit Care Med. 1989;17:301-2.
87. van Engelen BG, Gimbrere JS, Booy LH. Benzodiazepine withdrawal reaction in two children following discontinuation of sedation with midazolam. Ann Pharmacother. 1993;27:579-81.
88. Victory RA, Magee D. A case of convulsion after propofol anaesthesia. Anaesthesia. 1988;43:904.
89. Au J, Walker WS, Scott DH. Withdrawal syndrome after propofol infusion. Anaesthesia. 1990;45:741-2.
90. Boyle WA, Shear JM, White PF, Schuller D. Tolerance and hyperlipemia during long-term sedation with propofol. Anesthesiology. 1990;73:A245
91. Imray JM, Hay A. Withdrawal syndrome after propofol. Anaesthesia. 1991;46:704.
92. Valente JF, Anderson GL, Branson RD, Johnson DJ, Davis K, Jr., Porembka DT. Disadvantages of prolonged propofol sedation in the critical care unit. Crit Care Med. 1994;22:710-2.
93. Mirenda J, Broyles G. Propofol as used for sedation in the ICU. Chest 1995;108:539-48.
94. Mayhew JF, Abouleish AE. Lack of tolerance to propofol. Anesthesiology. 1996;85:1209.
95. Setlock MA, Palmisano BW, Berens RJ, Rosner DR, Troshynski TJ, Murray KJ. Tolerance to propofol generally does not develop in pediatric patients undergoing radiation therapy. Anesthesiology. 1996;85:207-9.
96. Buckley PM. Propofol in patients needing long-term sedation in intensive care. an assessment of the development of tolerance. A pilot study. Intensive Care Med. 1997;23:969-74.
97. Walder B, Tramer MR, Seeck M. Seizure-like phenomena and propofol. a systematic review. Neurology. 2002;58:1327-32.
98. Cawley MJ. Short-term lorazepam infusion and concern for propylene glycol toxicity: case report and review. Pharmacotherapy. 2001;21:1140-4.
99. Lane JC, Tennison MB, Lawless ST, Greenwood RS, Zaritsky AL. Movement disorder after withdrawal of fentanyl infusion. J Pediatr. 1991;119:649-51.
100. Arnold JH, Truog RD, Rice SA. Prolonged administration of isoflurane to pediatric patients during mechanical ventilation. Anesth Analg. 1993;76:520-6.
101. Katz R, Kelly HW. Pharmacokinetics of continuous infusions of fentanyl in critically ill children. Crit Care Med. 1993;21:995-1000.
102. Anand KJ, Arnold JH. Opioid tolerance and dependence in infants and children. Crit Care Med. 1994;22:334-42.
103. Tobias JD. Opioid withdrawal presenting as stridor. J Intensive Care Med. 1997;12:104-6.
104. Zapantis A, Leung S. Tolerance and withdrawal issues with sedation. Crit Care Nurs Clin North Am. 2005;17:211-23.
105. Roy-Byrne PP, Hommer D. Benzodiazepine withdrawal: overview and implications for the treatment of anxiety. Am J Med. 1988;84:1041-52.
106. Gold MS, Redmond DE, Jr., Kleber HD. Clonidine blocks acute opiate-withdrawal symptoms. Lancet. 1978;2:599-602.
107. Hoder EL, Leckman JF, Ehrenkranz R, Kleber H, Cohen DJ, Poulsen JA. Clonidine in neonatal narcotic-abstinence syndrome. N Engl J Med. 1981;305:1284.
108. Maccioli GA. Dexmedetomidine to facilitate drug withdrawal. Anesthesiology. 2003;98:575-7.
109. Multz AS. Prolonged dexmedetomidine infusion as an adjunct in treating sedation-induced withdrawal. Anesth Analg. 2003;96:1054-5.
110. Finkel JC, Elrefai A. The use of dexmedetomidine to facilitate opioid and benzodiazepine detoxification in an infant. Anesth Analg. 2004;98:1658-9.
111. Durbin CG, Jr.. Sedation of the agitated, critically ill patient without an artificial airway. Crit Care Clin. 1995;11:913-36.
112. Maccioli GA, Dorman T, Brown BR, Mazuski JE, McLean BA, Kuszaj JM, et al. Clinical practice guidelines for the maintenance of patient physical safety in the intensive care unit: use of restraining therapies - American College of Critical Care Medicine Task Force 2001-2002. Crit Care Med. 2003;31:2665-76.
113. Vance DL. Effect of a treatment interference protocol on clinical decision making for restraint use in the intensive care unit: a pilot study. AACN Clin Issues 2003;14:82-91.
114. Kapadia FN, Bajan KB, Raje KV. Airway accidents in intubated intensive care unit patients: an epidemiological study. Crit Care Med. 2000;28:659-64.
115. JCAHO. Comprehensive acreditation manual for long term care. Standards and intents for sedation and anesthesia care. 2001.
116. Practice parameters for systemic intravenous analgesia and sedation for adult patients in the intensive care unit. Official Statement of the Society of Critical Care Medicine. 1995.
117. Kollef MH, Levy NT, Ahrens TS, Schaiff R, Prentice D, Sherman G. The use of continuous i.v. sedation is associated with prolongation of mechanical ventilation. Chest. 1998;114:541-8.
118. Durbin CG, Jr.. Neuromuscular blocking agents and sedative drugs. Clinical uses and toxic effects in the critical care unit. Crit Care Clin. 1991;7:489-506.
119. Hansen-Flaschen JH, Brazinsky S, Basile C, Lanken PN. Use of sedating drugs and neuromuscular blocking agents in patients requiring mechanical ventilation for respiratory failure. A national survey. JAMA. 1991;266:2870-5.
120. Bair N, Bobek MB, Hoffman-Hogg L, Mion LC, Slomka J, Arroliga AC. Introduction of sedative, analgesic, and neuromuscular blocking agent guidelines in a medical intensive care unit. physician and nurse adherence. Crit Care Med. 2000;28: 707-13.
121. Brattebo G, Hofoss D, Flaatten H, Muri AK, Gjerde S, Plsek PE. Effect of a scoring system and protocol for sedation on duration of patients' need for ventilator support in a surgical intensive care unit. BMJ. 2002;324:1386-9.
122. Chanques G, Jaber S, Barbotte E, Violet S, Sebbane M, Perrigault PF, et al. Impact of systematic evaluation of pain and agitation in an intensive care unit. Crit Care Med. 2006;34:1691-9.
123. De Jonghe B, Bastuji-Garin S, Fangio P, Lacherade JC, Jabot J, ppere-De-Vecchi C, et al. Sedation algorithm in critically ill patients without acute brain injury. Crit Care Med. 2005;33:120-7.
124. Metheny NA, Clouse RE, Chang YH, Stewart BJ, Oliver DA, Kollef MH. Tracheobronchial aspiration of gastric contents in critically ill tube-fed patients. frequency, outcomes, and risk factors. Crit Care Med. 2006;34:1007-15.
125. Samuelson K, Lundberg D, Fridlund B. Memory in relation to depth of sedation in adult mechanically ventilated intensive care patients. Intensive Care Med. 2006;32:660-7.
126. Soltesz S, Biedler A, Silomon M, Schopflin I, Molter GP. Recovery after remifentanil and sufentanil for analgesia and sedation of mechanically ventilated patients after trauma or major surgery. Br J Anaesth. 2001;86:763-8.
127. Muellejans B, López A, Cross MH, Bonome C, Morrison L, Kirkham AJ. Remifentanil versus fentanyl for analgesia based sedation to provide patient comfort in the intensive care unit. a randomized, double-blind controlled trial. Crit Care. 2004;8:R1-R11.
128. Akinci SB, Kanbak M, Guler A, Aypar U. Remifentanil versus fentanyl for short-term analgesia-based sedation in mechanically ventilated postoperative children. Paediatr Anaesth. 2005;15:870-8.
129. Hall RI, Sandham D, Cardinal P, Tweeddale M, Moher D, Wang X, et al. Propofol vs midazolam for ICU sedation. a Canadian multicenter randomized trial. Chest. 2001;119:1151-9.
130. Carson SS, Kress JP, Rodgers JE, Vinayak A, Campbell-Bright S, Levitt J, et al. A randomized trial of intermittent lorazepam versus propofol with daily interruption in mechanically ventilated patients. Crit Care Med. 2006;34:1326-32.
131. Saito M, Terao Y, Fukusaki M, Makita T, Shibata O, Sumikawa K. Sequential use of midazolam and propofol for long-term sedation in postoperative mechanically ventilated patients. Anesth Analg. 2003;96:834-8.
132. Knibbe CA, Naber H, Aarts LP, Kuks PF, Danhof M. Long-term sedation with propofol 60 mg ml(-1) vs. propofol 10 mg(-1) ml in critically ill, mechanically ventilated patients. Acta Anaesthesiol Scand. 2004;48:302-7.
133. Venn RM, Bryant A, Hall GM, Grounds RM. Effects of dexmedetomidine on adrenocortical function, and the cardiovascular, endocrine and inflammatory responses in post-operative patients needing sedation in the intensive care unit. Br J Anaesth. 2001;86:650-6.
134. Malerba G, Romano-Girard F, Cravoisy A, Dousset B, Nace L, Levy B, et al. Risk factors of relative adrenocortical deficiency in intensive care patients needing mechanical ventilation. Intensive Care Med. 2005;31:388-92.
135. Kress JP, Pohlman AS, O'Connor MF, Hall JB. Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation. N Engl J Med. 2000;342:1471-7.
136. Schweickert WD, Gehlbach BK, Pohlman AS, Hall JB, Kress JP. Daily interruption of sedative infusions and complications of critical illness in mechanically ventilated patients. Crit Care Med. 2004;32:1272-6.
137. Brocas E, Dupont H, Paugam-Burtz C, Servin F, Mantz J, Desmonts JM. Bispectral index variations during tracheal suction in mechanically ventilated critically ill patients. effect of an alfentanil bolus. Intensive Care Med. 2002;28:211-3.
138. Triltsch AE, Welte M, von HP, Grosse J, Genahr A, Moshirzadeh M, et al. Bispectral index-guided sedation with dexmedetomidine in intensive care: a prospective, randomized, double blind, placebo-controlled phase II study. Crit Care Med. 2002;30:1007-14.
139. Nieszkowska A, Combes A, Luyt CE, Ksibi H, Trouillet JL, Gibert C, et al. Impact of tracheotomy on sedative administration, sedation level, and comfort of mechanically ventilated intensive care unit patients. Crit Care Med 2005;33:2527-33.
140. The Acute Respiratory Distress Syndrome Network Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med. 2000;342:1301-8.
141. Vinayak AG, Gehlbach B, Pohlman AS, Hall JB, Kress JP. The relationship between sedative infusion requirements and permissive hypercapnia in critically ill, mechanically ventilated patients. Crit Care Med. 2006;34:1668-73.
142. Cheng IW, Eisner MD, Thompson BT, Ware LB, Matthay MA. Acute effects of tidal volume strategy on hemodynamics, fluid balance, and sedation in acute lung injury. Crit Care Med. 2005;33:63-70.
143. Kahn JM, Andersson L, Karir V, Polissar NL, Neff MJ, Rubenfeld GD. Low tidal volume ventilation does not increase sedation use in patients with acute lung injury. Crit Care Med. 2005;33:766-71.
144. Ely EW, Baker AM, Dunagan DP, Burke HL, Smith AC, Kelly PT, et al. Effect on the duration of mechanical ventilation of identifying patients capable of breathing spontaneously. N Engl JMed. 1996;335:1864-9.
145. Kollef MH, Shapiro SD, Silver P, St John RE, Prentice D, Sauer S, et al. A randomized, controlled trial of protocol-directed versus physician-directed weaning from mechanical ventilation. Crit Care Med. 1997;25:567-74.
146. Marelich GP, Murin S, Battistella F, Inciardi J, Vierra T, Roby M. Protocol weaning of mechanical ventilation in medical and surgical patients by respiratory care practitioners and nurses. effect on weaning time and incidence of ventilator-associated pneumonia. Chest. 2000;118:459-67.
147. Smyrnios NA, Connolly A, Wilson MM, Curley FJ, French CT, Heard SO, et al. Effects of a multifaceted, multidisciplinary, hospital-wide quality improvement program on weaning from mechanical ventilation. Crit Care Med. 2002;30:1224-30.
148. Hurlock-Chorostecki C. Management of pain during weaning from mechanical ventilation:the nature of nurse decision-making. Can J Nurs Res. 2002;34:33-47.
149. Karabinis A, Mandragos K, Stergiopoulos S, Komnos A, Soukup J, Speelberg B, et al. Safety and efficacy of analgesia-based sedation with remifentanil versus standard hypnotic-based regimens in intensive care unit patients with brain injuries: a randomised, controlled trial. Crit Care. 2004;8:R268-R280
150. Breen D, Karabinis A, Malbrain M, Morais R, Albrecht S, Jarnvig IL, et al. Decreased duration of mechanical ventilation when comparing analgesia-based sedation using remifentanil with standard hypnotic-based sedation for up to 10 days in intensive care unit patients: a randomised trial. Crit Care. 2005;9:R200-R210.
151. Barrientos-Vega R, Sánchez-Soria M, Morales-García C, Robas-Gomez A, Cuena-Boy R, Ayensa-Rincon A. Prolonged sedation of critically ill patients with midazolam or propofol: impact on weaning and costs. Crit Care Med. 1997;25:33-40.
152. Walder B, Borgeat A, Suter PM, Romand JA. Propofol and midazolam versus propofol alone for sedation following coronary artery bypass grafting: a randomized, placebo-controlled trial. Anaesth Intensive Care. 2002;30:171-8.
153. Herr DL, Sum-Ping ST, England M. ICU sedation after coronary artery bypass graft surgery: dexmedetomidine-based versus propofol-based sedation regimens. J Cardiothorac Vasc Anesth. 2003;17:576-84.
154. Dahaba AA, Grabner T, Rehak PH, List WF, Metzler H. Remifentanil versus morphine analgesia and sedation for mechanically ventilated critically ill patients: a randomized double blind study. Anesthesiology. 2004;101:640-6.
155. Chinachoti T, Kessler P, Kirkham A, Werawatganon T. Remifentanil vs morphine for patients in intensive care unit who need short-term mechanical ventilation. J Med Assoc Thai. 2002;85 Suppl 3:S848-S857.
156. Kulkarni A, Price G, Saxena M, Skowronski G. Difficult extubation: calming the sympathetic storm. Anaesth Intensive Care. 2004;32:413-6.
157. Siobal MS, Kallet RH, Kivett VA, Tang JF. Use of dexmedetomidine to facilitate extubation in surgical intensive-care-unit patients who failed previous weaning attempts following prolonged mechanical ventilation: a pilot study. Respir Care. 2006;51:492-6.
158. Szumita PM, Baroletti SA, Anger KE, Wechsler ME. Sedation and analgesia in the intensive care unit: evaluating the role of dexmedetomidine. Am J Health Syst Pharm. 2007;64:37-44.
159. McCollam JS, O'Neil MG, Norcross ED, Byrne TK, Reeves ST. Continuous infusions of lorazepam, midazolam, and propofol for sedation of the critically ill surgery trauma patient: a prospective, randomized comparison. Crit Care Med. 1999;27:2454-8.
160. Beller JP, Pottecher T, Lugnier A, Mangin P, Otteni JC. Prolonged sedation with propofol in ICU patients: recovery and blood concentration changes during periodic interruptions in infusion. Br J Anaesth. 1988;61:583-8.
161. Ronan KP, Gallagher TJ, George B, Hamby B. Comparison of propofol and midazolam for sedation in intensive care unit patients. Crit Care Med. 1995;23:286-93.
162. Cremer OL, Moons KG, Bouman EA, Kruijswijk JE, de Smet AM, Kalkman CJ. Long-term propofol infusion and cardiac failure in adult head-injured patients. Lancet. 2001;357:117-8.
163. Shinozaki M, Usui Y, Yamaguchi S, Okuda Y, Kitajima T. Recovery of psychomotor function after propofol sedation is prolonged in the elderly. Can J Anaesth. 2002;49:927-31.
164. Pandharipande P, Shintani A, Peterson J, Pun BT, Wilkinson GR, Dittus RS, et al. Lorazepam is an independent risk factor for transitioning to delirium in intensive care unit patients. Anesthesiology. 2006;104:21-6.
165. http.//www.fda.gov/fdac/features/2001/301_preg.html. [Acceso 15-7-2007].
166. Tatro DS, Borgsdorf LR. A to Z Drug Facts. Edition. St Louis. http.//www.factsandcomparisons.com. [Acceso 13-5- 2007].
167. Higuchi H, Adachi Y, Arimura S, Kanno M, Satoh T. Early pregnancy does not reduce the C(50) of propofol for loss of consciousness. Anesth Analg. 2001;93:1565-9.
168. Jauniaux E, Gulbis B, Shannon C, Maes V, Bromley L, Rodeck C. Placental propofol transfer and fetal sedation during maternal general anaesthesia in early pregnancy. Lancet. 1998;352:290-1.
169. Numazaki M, Fujii Y. Subhypnotic dose of propofol for the prevention of nausea and vomiting during spinal anaesthesia for caesarean section. Anaesth Intensive Care. 2000;28:262-5.
170. Bonnot O, Vollset SE, Godet PF, d'Amato T, Robert E. Maternal exposure to lorazepam and anal atresia in newborns: results from a hypothesis-generating study of benzodiazepines and malformations. J ClinPsychopharmacol. 2001;21:456-8.
171. Bonnot O, Vollset SE, Godet PF, d'Amato T, Dalery J, Robert E. In utero exposure to benzodiazepine. Is there a risk for anal atresia with lorazepam?. Encephale. 2003;29:553-9.
172. www.fda.gov/cder/foi/label/2001/21038S1lbl.pdf. [Acceso 15-7-2007]
173. Wake PJ, Cheng DC. Postoperative intensive care in cardiac surgery. Curr Opin Anaesthesiol. 2001;14:41-5.
174. Dowd NP, Karski JM, Cheng DC, Gajula S, Seneviratne P, Munro JA, et al. Fast-track cardiac anaesthesia in the elderly:effect of two different anaesthetic techniques on mental recovery. Br J Anaesth. 2001;86:68-76.
175. Hall RI, MacLaren C, Smith MS, McIntyre AJ, Allen CT, Murphy JT, et al. Light versus heavy sedation after cardiac surgery: myocardial ischemia and the stress response. Anesth Analg. 1997;85:971-8.
176. O'Halloran P, Brown R. Patient-controlled analgesia compared with nurse-controlled infusion analgesia after heart surgery. Intensive Crit Care Nurs. 1997;13:126-9.
177. Checketts MR, Gilhooly CJ, Kenny GN. Patient-maintained analgesia with target-controlled alfentanil infusion after cardiac surgery. a comparison with morphine PCA. Br J Anaesth. 1998;80:748-51.
178. Hansdottir V, Philip J, Olsen MF, Eduard C, Houltz E, Ricksten SE. Thoracic epidural versus intravenous patient-controlled analgesia after cardiac surgery. A randomized controlled trial on length of hospital stay and patient-perceived quality of recovery. Anesthesiology. 2006;104:142-51.
179. Fitzpatrick GJ, Moriarty DC. Intrathecal morphine in the management of pain following cardiac surgery. A comparison with morphine i.v. Br J Anaesth. 1988;60:639-44.
180. Vanstrum GS, Bjornson KM, Ilko R. Postoperative effects of intrathecal morphine in coronary artery bypass surgery. Anesth Analg. 1988;67:261-7.
181. Chaney MA, Smith KR, Barclay JC, Slogoff S. Large-dose intrathecal morphine for coronary artery bypass grafting. Anesth Analg. 1996;83:215-22.
182. Zárate E, Latham P, White PF, Bossard R, Morse L, Douning LK, et al. Fast-track cardiac anesthesia. use of remifentanil combined with intrathecal morphine as an alternative to sufentanil during desflurane anesthesia. Anesth Analg. 2000;91: 283-7.
183. Bettex DA, Schmidlin D, Chassot PG, Schmid ER. Intrathecal sufentanil-morphine shortens the duration of intubation and improves analgesia in fast-track cardiac surgery. Can J Anaesth. 2002;49. 711-7.
184. Lena P, Balarac N, Arnulf JJ, Teboul J, Bonnet F. Intrathecal morphine and clonidine for coronary artery bypass grafting. Br J Anaesth. 2003;90:300-3.
185. Chaney MA, Nikolov MP, Blakeman BP, Bakhos M. Intrathecal morphine for coronary artery bypass graft procedure and early extubation revisited. J Cardiothorac Vasc Anesth. 1999;13:574-8.
186. Chaney MA, Furry PA, Fluder EM, Slogoff S. Intrathecal morphine for coronary artery bypass grafting and early extubation. Anesth Analg. 1997;84:241-8.
187. Roediger L, Joris J, Senard M, Larbuisson R, Canivet JL, Lamy M. The use of pre-operative intrathecal morphine for analgesia following coronary artery bypass surgery. Anaesthesia. 2006;61:838-44.
188. Alhashemi JA, Sharpe MD, Harris CL, Sherman V, Boyd D. Effect of subarachnoid morphine administration on extubation time after coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth. 2000;14:639-44.
189. Loick HM, Schmidt C, Van AH, Junker R, Erren M, Berendes E, et al. High thoracic epidural anesthesia, but not clonidine, attenuates the perioperative stress response via sympatholysis and reduces the release of troponin T in patients undergoing coronary artery bypass grafting. Anesth Analg. 1999;88: 701-9.
190. Ho AM, Chung DC, Joynt GM. Neuraxial blockade and hematoma in cardiac surgery: estimating the risk of a rare adverse event that has not (yet) occurred. Chest. 2000;117:.551-5.
191. Canto M, Sánchez MJ, Casas MA, Bataller ML. Bilateral paravertebral blockade for conventional cardiac surgery. Anaesthesia. 2003;58:365-70.
192. White PF, Rawal S, Latham P, Markowitz S, Issioui T, Chi L, et al. Use of a continuous local anesthetic infusion for pain management after median sternotomy. Anesthesiology. 2003;99: 918-23.
193. McDonald SB, Jacobsohn E, Kopacz DJ, Desphande S, Helman JD, Salinas F, et al. Parasternal block and local anesthetic infiltration with levobupivacaine after cardiac surgery with desflurane: the effect on postoperative pain, pulmonary function, and tracheal extubation times. Anesth Analg. 2005;100:25-32.
194. Rapanos T, Murphy P, Szalai JP, Burlacoff L, Lam-McCulloch J, Kay J. Rectal indomethacin reduces postoperative pain and morphine use after cardiac surgery. Can J Anaesth. 1999;46:725-30.
195. Hynninen MS, Cheng DC, Hossain I, Carroll J, Aumbhagavan SS, Yue R, et al. Non-steroidal anti-inflammatory drugs in treatment of postoperative pain after cardiac surgery. Can J Anaesth. 2000;47:1182-7.
196. Kadoi Y, Hinohara H, Kunimoto F, Saito S, Goto F. Fentanyl-induced hemodynamic changes after esophagectomy or cardiac surgery. J Clin Anesth. 2005;17:598-603.
197. Searle NR, Cote S, Taillefer J, Carrier M, Gagnon L, Roy M, et al. Propofol or midazolam for sedation and early extubation following cardiac surgery. Can J Anaesth. 1997;44:629-35.
198. Hsu YW, Cortinez LI, Robertson KM, Keifer JC, Sum-Ping ST, Moretti EW, et al. Dexmedetomidine pharmacodynamics part I: crossover comparison of the respiratory effects of dexmedetomidine and remifentanil in healthy volunteers. Anesthesiology. 2004;101:1066-76.
199. Ickeringill M, Shehabi Y, Adamson H, Ruettimann U. Dexmedetomidine infusion without loading dose in surgical patients requiring mechanical ventilation:haemodynamic effects and efficacy. Anaesth Intensive Care. 2004;32:741-5.
200. Alfonsi P. Postanaesthetic shivering: epidemiology, pathophysiology, and approaches to prevention and management. Drugs. 2001;61:2193-205.
201. Soliman HM, Melot C, Vincent JL. Sedative and analgesic practice in the intensive care unit: the results of a European survey. Br J Anaesth. 2001;87:186-92.
202. Vincent JL, Berre J. Primer on medical management of severe brain injury. Crit Care Med. 2005;33:1392-9.
203. Brain Trauma Foundation; American Association of Neurological Surgeons; Congress of Neurological Surgeons; Joint Section on Neurotrauma and Critical Care, AANS/CNS Guidelines for the Management of Severe Traumatic Brain Injury, 3rd. Edition. J Neurotrauma 2007;24 Supl 1:S71-S76.
204. Chesnut RM, Marshall LF, Klauber MR, Blunt BA, Baldwin N, Eisenberg HM, et al. The role of secondary brain injury in determining outcome from severe head injury. J Trauma. 1993;34:216-22.
205. de Nadal M, Munar F, Poca MA, Sahuquillo J, Garnacho A, Rossello J. Cerebral hemodynamic effects of morphine and fentanyl in patients with severe head injury: absence of correlation to cerebral autoregulation. Anesthesiology. 2000;92:11-9.
206. Sánchez-Izquierdo-Riera JA, Caballero-Cubedo RE, Pérez-Vela JL, Ambros-Checa A, Cantalapiedra-Santiago JA, Alted-López E. Propofol versus midazolam: safety and efficacy for sedating the severe trauma patient. Anesth Analg. 1998;86:1219-24.
207. Albanese J, Viviand X, Potie F, Rey M, Alliez B, Martin C. Sufentanil, fentanyl, and alfentanil in head trauma patients: a study on cerebral hemodynamics. Crit Care Med 1999;27:407-11.
208. Eisenberg HM, Frankowski RF, Contant CF, Marshall LF, Walker MD. High-dose barbiturate control of elevated intracranial pressure in patients with severe head injury. J Neurosurg. 1988;69:15-23.
209. Cormio M, Gopinath SP, Valadka A, Robertson CS. Cerebral hemodynamic effects of pentobarbital coma in head-injured patients. J Neurotrauma. 1999;16:927-36.
210. Bourgoin A, Albanese J, Wereszczynski N, Charbit M, Vialet R, Martin C. Safety of sedation with ketamine in severe head injury patients: comparison with sufentanil. Crit Care Med. 2003;31:711-7.
211. Dean M. Opioids in renal failure and dialysis patients. J Pain Symptom Manage. 2004;28:497-504.
212. Child CG, Turcotte J. Surgery and portal hypertension, The Liver and Portal Hypertension. Edited by Child C. Philadelphia, Saunders, 1964, p 50.
213. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973;60:646-9.
214. Yurdaydin C, Karavelioglu D, Onaran O, Celik T, Yasa MH, Uzunalimoglu O. Opioid receptor ligands in human hepatic encephalopathy. J Hepatol. 1998;29:796-801.
215. Assy N, Rosser BG, Grahame GR, Minuk GY. Risk of sedation for upper GI endoscopy exacerbating subclinical hepatic encephalopathy in patients with cirrhosis. Gastrointest Endosc. 1999;49:690-4.
216. Bergasa NV, Rothman RB, Mukerjee E, Vergalla J, Jones EA. Up-regulation of central mu-opioid receptors in a model of hepatic encephalopathy: a potential mechanism for increased sensitivity to morphine in liver failure. Life Sci. 2002;70:1701-8.
217. Vasudevan AE, Goh KL, Bulgiba AM. Impairment of psychomotor responses after conscious sedation in cirrhotic patients undergoing therapeutic upper GI endoscopy. Am J Gastroenterol. 2002;97:1717-21.
218. Kurella M, Bennett WM, Chertow GM. Analgesia in patients with ESRD: a review of available evidence. Am J Kidney Dis. 2003;42:217-28.
219. Heinrich L. Prescribing drugs for dialysis patients, Principles and practice of dialysis, 3rd Edition. Edited by Heinrich. Lippincott WW, 2004, p. 150-61.
220. Murphy EJ. Acute pain management pharmacology for the patient with concurrent renal or hepatic disease. Anaesth Intensive Care. 2005;33:311-22.
221. McGuire BM. Safety of endoscopy in patients with end-stage liver disease. Gastrointest Endosc Clin N Am. 2001;11:111-30.
222. Als-Nielsen B, Gluud LL, Gluud C. Dopaminergic agonists for hepatic encephalopathy. Cochrane Database Syst Rev. 2004;CD003047.
223. Weston BR, Chadalawada V, Chalasani N, Kwo P, Overley CA, Symms M, et al. Nurse-administered propofol versus midazolam and meperidine for upper endoscopy in cirrhotic patients. Am J Gastroenterol. 2003;98:2440-7.
224. Hohne C, Donaubauer B, Kaisers U. Opioids during anesthesia in liver and renal failure. Anaesthesist. 2004;53:291-303.
225. Pitsiu M, Wilmer A, Bodenham A, Breen D, Bach V, Bonde J, et al. Pharmacokinetics of remifentanil and its major metabolite, remifentanil acid, in ICU patients with renal impairment. Br J Anaesth. 2004;92:493-503.
226. Murray A, Hagen NA. Hydromorphone. J Pain Symptom Manage 2005;29. S 57-S 66.
227. De Wolf AM, Fragen RJ, Avram MJ, Fitzgerald PC, Rahimi-Danesh F. The pharmacokinetics of dexmedetomidine in volunteers with severe renal impairment. Anesth Analg. 2001;93:1205-9.
228. Venn RM, Karol MD, Grounds RM. Pharmacokinetics of dexmedetomidine infusions for sedation of postoperative patients requiring intensive caret. Br J Anaesth. 2002;88:669-75.
229. Swart EL, de Jonghe J, Zuideveld KP, Danhof M, Thijs LG, Strack van Schijndel RJ. Population pharmacokinetics of lorazepam and midazolam and their metabolites in intensive care patients on continuous venovenous hemofiltration. Am J Kidney. Dis 2005;45:360-71.
230. Eddleston JM, Pollard BJ, Blades JF, Doran B. The use of propofol for sedation of critically ill patients undergoing haemodiafiltration. Intensive Care Med. 1995;21:342-7.
231. Ickx B, Cockshott ID, Barvais L, Byttebier G, De PL, Vandesteene A, et al. Propofol infusion for induction and maintenance of anaesthesia in patients with end-stage renal disease. Br J Anaesth. 1998;81:854-60.
232. Barr J, Zaloga GP, Haupt MT, Weinmann M, Murray MJ, Bandi V, et al. Cation metabolism during propofol sedation with and without EDTA in patients with impaired renal function. Intensive Care Med. 2000;26 Suppl 4:S433-S442.
233. Sanga M, Shigemura J. Pharmacokinetics of haloperidol in patients on hemodialysis. Nihon Shinkei Seishin Yakurigaku Zasshi. 1998;18:45-7.
234. Nakasone H, Sugama R, Sakugawa H, Matayoshi R, Miyagi T, Maeshiro T, et al. Alcoholic liver cirrhosis complicated with torsade de pointes during plasma exchange and hemodiafiltration. J Gastroenterol. 2001;36:564-8.
235. Dumont L, Picard V, Marti RA, Tassonyi E. Use of remifentanil in a patient with chronic hepatic failure. Br J Anaesth. 1998;81:265-7
236. Ben Ari A, Elinav E, Elami A, Matot I. Off-pump coronary artery bypass grafting in a patient with Child class C liver cirrhosis awaiting liver transplantation. Br J Anaesth 2006;97: 468-72.
237. Blei AT, Cordoba J. Hepatic Encephalopathy. Am J Gastroenterol. 2001;96:1968-76.
238. Andersen G, Christrup L, Sjogren P. Relationships among morphine metabolism, pain and side effects during long-term treatment: an update. J Pain Symptom Manage. 2003;25:74-91.
239. Taura P, Fuster J, Blasi A, Martinez-Ocon J, Anglada T, Beltran J, et al. Postoperative pain relief after hepatic resection in cirrhotic patients: the efficacy of a single small dose of ketamine plus morphine epidurally. Anesth Analg. 2003;96:475-80.
240. Baughman VL. Pharmacokinetics/Pharmacodynamics effects of dexmedetomidine in patients with hepatic failure. Ed University of Illinois at Chicago. 2001.
241. Rovasalo A, Tohmo H, Aantaa R, Kettunen E, Palojoki R. Dexmedetomidine as an adjuvant in the treatment of alcohol withdrawal delirium: a case report. Gen Hosp Psychiatry. 2006;28:362-3.
242. Mayo-Smith MF, Beecher LH, Fischer TL, Gorelick DA, Guillaume JL, Hill A, et al. Management of alcohol withdrawal delirium. An evidence-based practice guideline. Arch Intern Med. 2004;164:1405-12.
243. Ntais C, Pakos E, Kyzas P, Ioannidis JP. Benzodiazepines for alcohol withdrawal. Cochrane. Database Syst Rev. 2005;CD005063.
244. Ebell MH. Benzodiazepines for alcohol withdrawal. Am Fam Physician. 2006;73:1191.
245. Wijdicks EF, Nyberg SL. Propofol to control intracranial pressure in fulminant hepatic failure. Transplant Proc. 2002;34:1220-2.
246. Jalan R. Intracranial hypertension in acute liver failure: pathophysiological basis of rational management. Semin Liver Dis. 2003;23:271-82.
247. Raghavan M, Marik PE. Therapy of intracranial hypertension in patients with fulminant hepatic failure. Neurocrit Care. 2006;4:179-89.
248. Faigel DO, Metz DC, Kochman ML. Torsade de pointes complicating the treatment of bleeding esophageal varices: association with neuroleptics, vasopressin, and electrolyte imbalance. Am J Gastroentero.l 1995;90:822-4.
249. Strouse TB. Neuropsychiatric outcomes in liver trauma. Transplantation of the liver. Eds. Busittil and Klintman. W.B Saunders Company Philadelphia, 1996, pp 660-1.
250. Prabhakar S, Bhatia R. Management of agitation and convulsions in hepatic encephalopathy. Indian J Gastroenterol. 2003;22:(Suppl 2):S54-S58.
251. Moon MR, Luchette FA, Gibson SW, Crews J, Sudarshan G, Hurst JM, et al. Prospective, randomized comparison of epidural versus parenteral opioid analgesia in thoracic trauma. Ann Surg. 1999;229:684-91.
252. Flisberg P, Rudin A, Linner R, Lundberg CJ. Pain relief and safety after major surgery. A prospective study of epidural and intravenous analgesia in 2696 patients. Acta Anaesthesiol Scand. 2003;47:457-65.
253. Bulger EM, Edwards T, Klotz P, Jurkovich GJ. Epidural analgesia improves outcome after multiple rib fractures. Surgery. 2004;136:426-30.
254. Bimston DN, McGee JP, Liptay MJ, Fry WA. Continuous paravertebral extrapleural infusion for post-thoracotomy pain management. Surgery. 1999;126:650-6.
255. Richardson J, Sabanathan S, Jones J, Shah RD, Cheema S, Mearns AJ. A prospective, randomized comparison of preoperative and continuous balanced epidural or paravertebral bupivacaine on post-thoracotomy pain, pulmonary function and stress responses. Br J Anaesth. 1999;83:387-92.
256. Dhole S, Mehta Y, Saxena H, Juneja R, Trehan N. Comparison of continuous thoracic epidural and paravertebral blocks for postoperative analgesia after minimally invasive direct coronary artery bypass surgery. J Cardiothorac Vasc Anesth. 2001;15:288-92.
257. Davies RG, Myles PS, Graham JM. A comparison of the analgesic efficacy and side-effects of paravertebral vs epidural blockade for thoracotomy - a systematic review and meta-analysis of randomized trials. Br J Anaesth. 2006;96:418-26.
258. Luketich JD, Land SR, Sullivan EA, Velo-Rivera M, Ward J, Buenaventura PO, et al. Thoracic epidural versus intercostal nerve catheter plus patient-controlled analgesia: a randomized study. Ann Thorac Surg. 2005;79:1845-9.
259. Krachman SL, D'Alonzo GE, Criner GJ. Sleep in the intensive care unit. Chest. 1995;107:1713-20.
260. Gabor JY, Cooper AB, Hanly PJ. Sleep disruption in the intensive care unit. Curr Opin Crit Care. 2001;7:21-7.
261. Freedman NS, Kotzer N, Schwab RJ. Patient perception of sleep quality and etiology of sleep disruption in the intensive care unit. Am J Respir Crit Care Med. 1999;159:1155-62.
262. Nicolás A, Aizpitarte E, Iruarrizaga A, Vázquez M, Margall MA, Asiain MC. Perception of night-time sleep by the surgical patients in an Intensive Care Unit. Enferm Intensiva. 2002;13:57-67.
263. Gabor JY, Cooper AB, Crombach SA, Lee B, Kadikar N, Bettger HE, et al. Contribution of the intensive care unit environment to sleep disruption in mechanically ventilated patients and healthy subjects. Am J Respir Crit Care Med. 2003;167:708-15.
264. Richards K, Nagel C, Markie M, Elwell J, Barone C. Use of complementary and alternative therapies to promote sleep in critically ill patients. Crit Care Nurs Clin North Am. 2003;15: 329-40.
265. Walder B, Haase U, Rundshagen I. Sleep disturbances in critically ill patients. Anaesthesist 2007;56:7-17.
266. Frisk U, Nordstrom G. Patients' sleep in an intensive care unit-patients' and nurses' perception. Intensive Crit Care Nurs. 2003;19:342-9.
267. Freedman NS, Gazendam J, Levan L, Pack AI, Schwab RJ. Abnormal sleep/wake cycles and the effect of environmental noise on sleep disruption in the intensive care unit. Am J Respir Crit Care Med. 2001;163:451-7.
268. Donchin Y, Seagull FJ. The hostile environment of the intensive care unit. Curr Opin Crit Care. 2002;8:316-20.
269. van de Leur JP, van der Schans CP, Loef BG, Deelman BG, Geertzen JH, Zwaveling JH. Discomfort and factual recollection in intensive care unit patients. Crit Care. 2004;8:R467-R473.
270. Aaron JN, Carlisle CC, Carskadon MA, Meyer TJ, Hill NS, Millman RP. Environmental noise as a cause of sleep disruption in an intermediate respiratory care unit. Sleep. 1996;19:707-10.
271. Walder B, Francioli D, Meyer JJ, Lancon M, Romand JA. Effects of guidelines implementation in a surgical intensive care unit to control nighttime light and noise levels. Crit Care Med. 2000;28:2242-7.
272. Richards KC. Effect of a back massage and relaxation intervention on sleep in critically ill patients. Am J Crit Care. 1998;7:288-99.
273. Hayes J, Cox C. Immediate effects of a five-minute foot massage on patients in critical care. Intensive Crit Care Nurs. 1999;15:77-82.
274. Tsay SL, Wang JC, Lin KC, Chung UL. Effects of acupressure therapy for patients having prolonged mechanical ventilation support. J Adv Nurs. 2005;52:142-50.
275. Byers JF, Smyth KA. Effect of a music intervention on noise annoyance, heart rate, and blood pressure in cardiac surgery patients. Am J Crit Care. 1997;6:183-91.
276. Johnston K, Rohaly-Davis J. An introduction to music therapy: helping the oncology patient in the ICU. Crit Care Nurs Q. 1996;18:54-60.
277. Chlan L. Effectiveness of a music therapy intervention on relaxation and anxiety for patients receiving ventilatory assistance. Heart Lung. 1998;27:169-76.
278. Chlan L, Tracy MF, Nelson B, Walker J. Feasibility of a music intervention protocol for patients receiving mechanical ventilatory support. Altern Ther Health Med. 2001;7:80-3.
279. Chlan LL. Music therapy as a nursing intervention for patients supported by mechanical ventilation. AACN Clin Issues. 2000;11:128-38.
280. Wong HL, López-Nahas V, Molassiotis A. Effects of music therapy on anxiety in ventilator-dependent patients. Heart Lung. 2001;30:376-87.
281. Lee OK, Chung YF, Chan MF, Chan WM. Music and its effect on the physiological responses and anxiety levels of patients receiving mechanical ventilation: a pilot study. J Clin Nurs. 2005;14:609-20.
282. Jaber S, Bahloul H, Guetin S, Chanques G, Sebbane M, Eledjam JJ. Effects of music therapy in intensive care unit without sedation in weaning patients versus non-ventilated patients. Ann Fr Anesth Reanim. 2007;26:30-8.
283. Almerud S, Petersson K. Music therapy-a complementary treatment for mechanically ventilated intensive care patients. Intensive Crit Care Nurs. 2003;19:21-30.
284. Novaes MA, Aronovich A, Ferraz MB, Knobel E. Stressors in ICU:patients' evaluation. Intensive Care Med. 1997;23:1282-5.